Drontal Junior, 15mg+14,4mg/1 ml, zawiesina doustna dla psów
Drontal Junior, 15mg+14,4mg/1 ml, zawiesina doustna dla psów
Authorised
- Pyrantel embonate
- Febantel
Product identification
Medicine name:
Drontal Junior, 15mg+14,4mg/1 ml, zawiesina doustna dla psów
Active substance:
- Pyrantel embonate
- Febantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Pyrantel embonate14.40/milligram(s)1.00millilitre(s)
-
Febantel150.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AE52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Available in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol Biowet Sp. z o.o.
- KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 0630
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
